Abrdn PLC Ultragenyx Pharmaceutical Inc. Transaction History
Abrdn PLC
- $51.7 Billion
- Q4 2024
A detailed history of Abrdn PLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Abrdn PLC holds 317,125 shares of RARE stock, worth $14 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
317,125
Previous 253,304
25.2%
Holding current value
$14 Million
Previous $14.1 Million
5.19%
% of portfolio
0.03%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding RARE
# of Institutions
325Shares Held
85.6MCall Options Held
520KPut Options Held
406K-
Vanguard Group Inc Valley Forge, PA9.95MShares$438 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$247 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.12MShares$225 Million0.91% of portfolio
-
Wellington Management Group LLP Boston, MA4.17MShares$183 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.07MShares$135 Million0.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.09B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...